Phenylimidazolidine derivatives and their use
US5424293A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Jul 22, 1993 |
| Grant date | Jun 13, 1995 |
| Priority date | — |
| Expiry date | Jul 22, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Phenylimidazolidine derivatives of the general formula I ##STR1## in which, for example, Y denotes --CH.sub.2 --CH.sub.2 --CO-- PA1 r denotes 0 to 3 PA1 Z denotes oxygen PA1 W denotes hydroxyl PA1 R.sup.1 denotes --NH--C(.dbd.NH)--NH.sub.2 PA1 R, R.sup.2, R.sup.3 denote hydrogen PA1 R.sup.4 denotes --CO--NHR.sup.5, where --NH--R.sup.5 represents an .alpha.-amino acid radical, have useful pharmacological properties such as inhibition of platelet aggregation and osteoclast binding to the bone surfaces.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.